Log in

NASDAQ:PAVM - PAVmed Stock Price, Forecast & News

$1.80
-0.01 (-0.55 %)
(As of 03/29/2020 04:00 PM ET)
Today's Range
$1.71
Now: $1.80
$1.84
50-Day Range
$1.37
MA: $2.10
$3.29
52-Week Range
$0.81
Now: $1.80
$3.45
Volume331,411 shs
Average Volume1.14 million shs
Market Capitalization$68.60 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.73
PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.
Read More
PAVmed logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAVM
CUSIPN/A
Phone212-949-4319

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.17) per share

Profitability

Net Income$-17,970,000.00

Miscellaneous

Employees9
Market Cap$68.60 million
Next Earnings Date4/9/2020 (Confirmed)
OptionableNot Optionable

Receive PAVM News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter.


PAVmed (NASDAQ:PAVM) Frequently Asked Questions

How has PAVmed's stock been impacted by COVID-19 (Coronavirus)?

PAVmed's stock was trading at $1.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PAVM stock has increased by 3.4% and is now trading at $1.80. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of PAVmed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for PAVmed.

When is PAVmed's next earnings date?

PAVmed is scheduled to release its next quarterly earnings announcement on Thursday, April 9th 2020. View our earnings forecast for PAVmed.

How can I listen to PAVmed's earnings call?

PAVmed will be holding an earnings conference call on Thursday, April 9th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were PAVmed's earnings last quarter?

PAVmed Inc (NASDAQ:PAVM) released its quarterly earnings results on Thursday, November, 15th. The company reported ($0.08) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.12) by $0.04. View PAVmed's earnings history.

What price target have analysts set for PAVM?

1 brokers have issued 12-month price targets for PAVmed's shares. Their forecasts range from $5.00 to $5.00. On average, they expect PAVmed's stock price to reach $5.00 in the next year. This suggests a possible upside of 177.8% from the stock's current price. View analysts' price targets for PAVmed.

Has PAVmed been receiving favorable news coverage?

News stories about PAVM stock have been trending extremely negative on Sunday, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PAVmed earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news aboutPAVmed.

Are investors shorting PAVmed?

PAVmed saw a decrease in short interest during the month of March. As of March 13th, there was short interest totaling 1,904,600 shares, a decrease of 16.1% from the February 27th total of 2,270,000 shares. Based on an average trading volume of 1,301,600 shares, the short-interest ratio is currently 1.5 days. Currently, 7.3% of the shares of the stock are short sold. View PAVmed's Current Options Chain.

Who are some of PAVmed's key competitors?

What other stocks do shareholders of PAVmed own?

Who are PAVmed's key executives?

PAVmed's management team includes the following people:
  • Dr. Lishan Aklog M.D., Chairman & CEO (Age 53)
  • Mr. Dennis M. McGrath CPA, Pres, CFO & Sec. (Age 62)
  • Dr. Brian J. deGuzman M.D., Chief Medical Officer (Age 54)
  • Mike Havrilla, Director of Investor Relations
  • Mr. Shaun M. O'Neil, Chief Commercial Officer

What is PAVmed's stock symbol?

PAVmed trades on the NASDAQ under the ticker symbol "PAVM."

Who are PAVmed's major shareholders?

PAVmed's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Levin Capital Strategies L.P. (0.16%) and Virtu Financial LLC (0.05%). Company insiders that own PAVmed stock include Dennis M Mcgrath, Ira Scott Greenspan and Lishan Aklog. View institutional ownership trends for PAVmed.

Which institutional investors are buying PAVmed stock?

PAVM stock was acquired by a variety of institutional investors in the last quarter, including Levin Capital Strategies L.P., and Virtu Financial LLC. Company insiders that have bought PAVmed stock in the last two years include Dennis M Mcgrath, and Lishan Aklog. View insider buying and selling activity for PAVmed.

How do I buy shares of PAVmed?

Shares of PAVM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PAVmed's stock price today?

One share of PAVM stock can currently be purchased for approximately $1.80.

How big of a company is PAVmed?

PAVmed has a market capitalization of $68.60 million. PAVmed employs 9 workers across the globe. View additional information about PAVmed.

What is PAVmed's official website?

The official website for PAVmed is http://www.pavmed.com/.

How can I contact PAVmed?

PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The company can be reached via phone at 212-949-4319 or via email at [email protected]


MarketBeat Community Rating for PAVmed (NASDAQ PAVM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  171 (Vote Underperform)
Total Votes:  356
MarketBeat's community ratings are surveys of what our community members think about PAVmed and other stocks. Vote "Outperform" if you believe PAVM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAVM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: What are retained earnings?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel